(Reuters) -GSK's CEO Emma Walmsley will step down at the end of the year and be replaced by insider Luke Miels, the drugmaker said on Monday, a surprise switch as the British firm looks to rev up its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback